Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985–2006)
KA MacDonald, O Cagney… - Journal of the American …, 2009 - Am Vet Med Assoc
Objective—To evaluate sensitivity and specificity of echocardiography for diagnosis of
cardiac masses in dogs with pericardial effusion. Design—Retrospective case series …
cardiac masses in dogs with pericardial effusion. Design—Retrospective case series …
Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome
RA Maselli, JJ Ng, JA Anderson, O Cagney… - Journal of medical …, 2009 - jmg.bmj.com
Background: We describe a severe form of congenital myasthenic syndrome (CMS)
associated with congenital nephrosis and ocular malformations caused by two truncating …
associated with congenital nephrosis and ocular malformations caused by two truncating …
[HTML][HTML] Metagenomic insights of the infant microbiome community structure and function across multiple sites in the United States
…, H Brown, RD Mitchell, S Kazi, S Chew, O Cagney… - Scientific Reports, 2021 - nature.com
The gut microbiome plays an important role in early life, protecting newborns from enteric
pathogens, promoting immune system development and providing key functions to the infant …
pathogens, promoting immune system development and providing key functions to the infant …
LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z−) agrin
RA Maselli, JM Fernandez, J Arredondo, C Navarro… - Human genetics, 2012 - Springer
We describe a severe form of congenital myasthenic syndrome (CMS) caused by two
heteroallelic mutations: a nonsense and a missense mutation in the gene encoding agrin …
heteroallelic mutations: a nonsense and a missense mutation in the gene encoding agrin …
Mutations in MUSK causing congenital myasthenic syndrome impair MuSK–Dok-7 interaction
RA Maselli, J Arredondo, O Cagney… - Human molecular …, 2010 - academic.oup.com
We describe a severe congenital myasthenic syndrome (CMS) caused by two missense
mutations in the gene encoding the muscle specific receptor tyrosine kinase (MUSK). The …
mutations in the gene encoding the muscle specific receptor tyrosine kinase (MUSK). The …
Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE
RA Maselli, J Arredondo, O Cagney… - Clinical …, 2011 - Wiley Online Library
Maselli RA, Arredondo J, Cagney O, Mozaffar T, Skinner S, Yousif S, Davis RR, Gregg JP,
Sivak M, Konia TH, Thomas K, Wollmann RL. Congenital myasthenic syndrome associated …
Sivak M, Konia TH, Thomas K, Wollmann RL. Congenital myasthenic syndrome associated …
[HTML][HTML] B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit
…, KA Winn, S Norman, RD Mitchell, O Cagney… - Frontiers in …, 2022 - frontiersin.org
Not all infants carry specialized gut microbes, meaning they cannot digest human milk
oligosaccharides and therefore do not receive complete benefits from human milk. B. infantis …
oligosaccharides and therefore do not receive complete benefits from human milk. B. infantis …
[HTML][HTML] The efficacy and safety of medicinal cannabis in adult populations: an evidence review.
Methods This evidence review comprises an overview of reviews (umbrella review). The
methods used in this review are divided into five stages: identifying research evidence; …
methods used in this review are divided into five stages: identifying research evidence; …
[PDF][PDF] Reablement in the home for people aged 65 years and over: components, effectiveness, and influencing factors
M Keane, O Cagney, A Cochrane, C Lee, A Farragher… - 2021 - hrb.ie
Purpose The objective of this evidence review is to bring together international evidence
and feed into the Department of Health's consideration of a national policy framework for …
and feed into the Department of Health's consideration of a national policy framework for …
[PDF][PDF] The efficacy and safety of medicinal cannabis in adult populations: A protocol for an overview of reviews
K Lambe, Á Teahan, O Cagney, C Lee, J Long - 2022 - crd.york.ac.uk
1 Background In January 2017, the Health Products Regulatory Authority (HPRA), at the
request of the Minister for Health, convened an expert working group to review the potential …
request of the Minister for Health, convened an expert working group to review the potential …